Ecuador president going to U.S. cancer centre following melanoma diagnosis
Foreign
ECUADOR President Guillermo Lasso is traveling to a U.S. hospital known for its cancer treatment for medical tests and will likely have surgery there.
Lasso, a former banker and businessman, said this at a news conference before departing for Houston.
He will be travelling after he was diagnosed with melanoma on his right eyelid, and added that it would not affect his presidential duties.
Lasso, who took office in May of last year, underwent surgery on July 29 to remove a carcinoma in the lower part of the eyelid, but will follow up with more tests at his doctor’s recommendation.
The Ecuadorian president said he was going to the MD Anderson Cancer Center in Houston.
“I feel very good,” Lasso told reporters before departing.
“It is an issue that must be dealt with to prevent it from spreading in the future, in this case, all over my face,” he added.
Lasso said he will likely have another surgery on his eyelid on Thursday.
It is the second time Lasso has traveled to the United States for health issues.
In June 2021, he had surgery to remove a cyst in his lower back.
The president also said that before his trip, he was able to determine the topics of a popular vote set to take place next year.
Lasso is scheduled to return from the U.S. on Aug. 21. (Reuters/NAN)
A.I
Related Posts
Koreans, Nigerians celebrate 2024 Nobel Prize laureate, Han Kang
KOREANS and Nigerians in Federal Capital Territory (FCT), on Friday celebrated Korean literary icon, Han Kang, for winning the 2024 Nobel...
Read MoreMorocco accelerates regionalisation process with 4 new agreements
TANGIER (Morocco), Dec. 21, 2024 (NAN) The Kingdom of Morocco’s 12 regions and several ministerial departments, have signed four framework...
Read MoreSouth Korean President Fails To Appear Before Corruption Watchdog
SOUTH Korea’s impeached President Yoon Suk Yeol failed to appear before the country’s corruption watchdog on Wednesday, it said, after...
Read MoreMost Read
Subscribe to Our Newsletter
Keep abreast of news and other developments from our website.